Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Veeda Clinical Research Successfully Completed its 5th WHO Audit 2018-11-05 07:00
I-Mab and Genexine Announce China IND Approval for Innovative Immunotherapy 2018-11-02 21:11
China Biologic Reports Financial Results for the Third Quarter of 2018 2018-11-02 04:30
Metrics Contract Services Adds Commercial Gerteis Roller Compaction Capabilities 2018-11-01 20:00
Strategic Cooperation between GeneQuantum Healthcare and Biocytogen on Development of Antitumor Bioconjugates 2018-11-01 10:00
Adagene Announces First Patient Dosed in United States and Acceptance of IND in China for ADG-106 2018-11-01 08:00
WuXi Biologics Commenced Construction of 48,000L Biologics Commercial Manufacturing Center in Shijiazhuang 2018-10-31 16:08
GC Pharma Reports Q3 2018 Results 2018-10-30 16:33
CStone announces first patient dosed in Phase I study in China for MEK inhibitor CS3006 2018-10-30 10:28
L.E.A.F. Pharmaceuticals Receives Positive US FDA Feedback and Comprehensive Roadmap for Clinical Development as well as Registration of its Four Lead Novel Anticancer Drugs 2018-10-30 05:47
Tychan Successfully Completes Human Safety Studies for the First-in-Class Potent Monoclonal Antibody against Zika Virus 2018-10-29 21:29
Progress Update on GDC-0084 Program 2018-10-29 18:00
Mayne Pharma Acquires FDA-approved halobetasol foam, Complementing US Dermatology Portfolio 2018-10-26 12:22
China Biologic Products to Report Third Quarter 2018 Financial Results 2018-10-24 20:00
TaiwanJ Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Study of JKB-122 on Non-Alcoholic Fatty Liver Disease (NAFLD) 2018-10-24 15:28
CStone Receives US FDA IND Approval for Recombinant PD-1 mAb CS1003 2018-10-24 10:08
Cerecin appoints veteran Singaporean Pharmaceutical Executive, Cheryl Tan, as Head of Commercial Strategy 2018-10-24 09:00
NeuClone Announces First Human Dose of Herceptin® (trastuzumab) Biosimilar Candidate in Phase I Clinical Trial 2018-10-23 21:00
KN035, a Global Leading Subcutaneously-administered PD-L1 Antibody, Starts Late-stage Clinical Development 2018-10-23 19:03
Reistone Biopharma, a new Chinese biotech company ready to initiate its Ulcerative Colitis phase II clinical trial globally 2018-10-22 22:00
1 343 344 345 346 347 411